Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial
GastroenterologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- European journal of cancer (Oxford, England : 1990)
- Publicado em
- 30 nov 2024
- Citações
- 9
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial
De-Shen Wang, William Pat Fong, Lei Wen, Yan-Yu Cai, Chao Ren, Xiao-Jun Wu, Tian-Qi Zhang, Fei Cao, Meng-Xuan Zuo, Bin-Kui Li et al.
Descritores MeSH
- Leucovorin
- Infusions, Intra-Arterial
- Liver Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Floxuridine
- Fluorouracil
- Colorectal Neoplasms
- Hepatic Artery
- Metastasectomy
- Humans
Veja também
Estudos relacionados
- Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases
- Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial
- Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis
- Efficacy of various adjuvant chemotherapy methods in preventing liver metastasis from potentially curative colorectal cancer: A systematic review network meta-analysis of randomized clinical trials
- Eficácia comparativa de tratamentos adjuvantes comuns após ressecção de metástases hepáticas colorretais: revisão sistemática e metanálise de rede